Puma biotechnologies shop
Puma biotechnologies shop
Puma biotechnologies shop
Puma biotechnologies shop
Puma biotechnologies shop
Puma biotechnologies shop

Puma biotechnologies shop

Puma biotechnologies shop, Puma Biotechnology Announces Presentation of Findings from a Phase I II Study of Alisertib and Pembrolizumab for Rb Deficient Head and Neck Squamous Cell Carcinomas at the 2023 AACR NCI EORTC Molecula... shop

$45.00

SKU: 7471401

Colour
  • Puma Biotechnology Announces 10 Million Private Placement Business Wire
  • Puma Biotechnology Announces 10 Million Private Placement Business Wire
  • Puma Biotechnology Inc. LinkedIn
  • Puma Biotechnology Receives FDA Orphan Drug Designation for Alisertib for the Treatment of Small Cell Lung Cancer PharmiWeb
Out of stock
Personalised:
: ( x )
Personalisation:
Edit
Remove Personalisation
Frasers Plus

Buy now.

Pay later.

Earn rewards

Representative APR: 29.9% (variable)

Credit subject to status. Terms apply.

Missed payments may affect your credit score

FrasersPlus